
The main application for the MegaPlex technology developed by University of Leicester researchers, is in medium scale genomic analysis (such as targeted Next Generation Sequencing, high-plex genotyping, and sample identification/fingerprinting) in areas such as biomedical research, clinical diagnostics, agricultural/livestock quality control, and environmental monitoring. These are all large markets, for example the in vitro diagnostics market is expected to reach $16.38Bn globally, with rapid growth between 2013 to 2023, with molecular diagnostics already representing 18% of the >$10Bn IVD market in Europe alone in 2014.
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.